University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Vadim Gladyshev Publications

Biochemistry, Department of

April 2007

Selenoprotein H Is a Nucleolar Thioredoxin-like Protein with a
Unique Expression Pattern
Sergey V. Novoselov
University of Nebraska-Lincoln

Gregory V. Kryukov
University of Nebraska-Lincoln

Xue-Ming Xu
NCI, National Institutes of Health, Bethesda, Maryland 20892

Bradley A. Carlson
NCI, National Institutes of Health, Bethesda, Maryland 20892

Dolph L. Hatfield
NCI, National Institutes of Health, Bethesda, Maryland 20892
See next page for additional authors

Follow this and additional works at: https://digitalcommons.unl.edu/biochemgladyshev
Part of the Biochemistry, Biophysics, and Structural Biology Commons

Novoselov, Sergey V.; Kryukov, Gregory V.; Xu, Xue-Ming; Carlson, Bradley A.; Hatfield, Dolph L.; and
Gladyshev, Vadim N., "Selenoprotein H Is a Nucleolar Thioredoxin-like Protein with a Unique Expression
Pattern" (2007). Vadim Gladyshev Publications. 55.
https://digitalcommons.unl.edu/biochemgladyshev/55

This Article is brought to you for free and open access by the Biochemistry, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Vadim Gladyshev
Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Authors
Sergey V. Novoselov, Gregory V. Kryukov, Xue-Ming Xu, Bradley A. Carlson, Dolph L. Hatfield, and Vadim N.
Gladyshev

This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
biochemgladyshev/55

Supplemental Material can be found at:
http://www.jbc.org/cgi/content/full/M701605200/DC1
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 282, NO. 16, pp. 11960 –11968, April 20, 2007
Printed in the U.S.A.

Selenoprotein H Is a Nucleolar Thioredoxin-like Protein with
a Unique Expression Pattern*□
S

Received for publication, September 10, 2006, and in revised form, February 23, 2007 Published, JBC Papers in Press, March 1, 2007, DOI 10.1074/jbc.M701605200

Sergey V. Novoselov‡1, Gregory V. Kryukov‡2, Xue-Ming Xu§, Bradley A. Carlson§, Dolph L. Hatfield§,
and Vadim N. Gladyshev‡3
From the ‡Department of Biochemistry, University of Nebraska, Lincoln, Nebraska 68588 and §Molecular Biology of Selenium
Section, Laboratory of Cancer Prevention, Center for Cancer Research, NCI, National Institutes of Health,
Bethesda, Maryland 20892

Selenium is an essential trace element with significant biomedical potential and roles in human health (1). As a dietary

* This study was supported by National Institutes of Health Grant GM061603
(to V. N. G.) and, in part, by the Intramural Research Program of the NCI,
Center for Cancer Research, National Institutes of Health. The use of 75Se
was supported by DoE DE-FG07-02ID14380. The costs of publication of this
article were defrayed in part by the payment of page charges. This article
must therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
□
S
The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. S1–S3, Table S1, and references.
1
Present Address: Institute of Cell Biophysics, Russian Academy of Sciences,
Pushchino, Mascow region 142292, Russia.
2
Present address: Div. of Genetics, Dept. of Medicine, Brigham and Women’s
Hospital and Harvard Medical School, New Research Bldg., 77 Ave. Louis
Pasteur, Boston, MA 02115.
3
To whom correspondence should be addressed. E-mail: vgladyshev1@unl.edu.

11960 JOURNAL OF BIOLOGICAL CHEMISTRY

supplement, selenium has been shown to serve as a cancer chemopreventive agent and has roles in immune function, mammalian development, male reproduction, and in preventing
heart disease and other cardiovascular and muscle disorders
(for reviews, see Ref. 2). Its biological significance is attributed
to the occurrence of this element in proteins in the form of
selenocysteine (Sec),4 the 21st amino acid in the genetic code
(3). This rare, highly reactive amino acid (4) is encoded by the
UGA codon and is incorporated into proteins co-translationally (5–7). Sec-specific incorporation requires the presence of
cis- and trans-acting elements. In addition to UGA, a stem-loop
structure known as the SECIS (selenocysteine insertion
sequence) element operates as the cis element for Sec incorporation (8 –10). In eukaryotes, SECIS is located in 3⬘-UTRs of
selenoprotein mRNAs and interacts with trans-acting factors.
Recently, an additional recoding element was identified in a
subset of eukaryotic selenoprotein genes that is adjacent to Secencoding UGA codons (11). In eukaryotes, the trans-acting factors consist of Sec tRNA (12–15), selenocysteyl-tRNA-specific
elongation factor (14, 15), and SBP2 (SECIS-binding protein 2)
(16, 17). These three components function together to redefine
the UGA codon to dictate Sec insertion (6, 18). Ribosomal protein L30 has also been shown to be a component of the eukaryotic Sec recoding machinery (19).
Selenoproteins are present in all kingdoms of life, and the full
set of such proteins in a particular organism is known as the
selenoproteome. The human selenoproteome consists of 25
proteins, whereas rodents have 24 such proteins (20). About
half of these proteins (e.g. glutathione peroxidases (21) and thioredoxin reductases (22)) play roles in various redox reactions,
but functions of the remaining selenoproteins are not known.
Therefore, to understand the effects of selenium on human
health and to explain how these effects are governed by dietary
dependence on selenium, the functions of all selenoproteins
need to be elucidated.
Selenoprotein H (SelH) is a recently discovered 14-kDa
mammalian protein with no homology to functionally characterized proteins (20). However, certain similarities to other selenoproteins can be seen, particularly a conserved Cys-XaaXaa-Sec (CXXU) motif wherein cysteine and Sec are separated

4

The abbreviations used are: Sec, selenocysteine; SelH, selenoprotein H; GFP,
green fluorescent protein; GPx, glutathione peroxidase; t-BOOH, tert-butyl
hydroperoxide; PBS, phosphate-buffered saline; NLS, nuclear localization
signal; DAPI, 4⬘,6-diamidino-2-phenylindole.
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The human selenoproteome consists of 25 known selenoproteins, but functions of many of these proteins are not known. Selenoprotein H (SelH) is a recently discovered 14-kDa mammalian
protein with no sequence homology to functionally characterized
proteins. By sensitive sequence and structure analyses, we identified SelH as a thioredoxin fold-like protein in which a conserved
CXXU motif (cysteine separated by two other residues from selenocysteine) corresponds to the CXXC motif in thioredoxins. These
data suggest a redox function of SelH. Indeed, a recombinant SelH
shows significant glutathione peroxidase activity. In addition, SelH
has a conserved RKRK motif in the N-terminal sequence. We
cloned wild-type and cysteine mutant forms of SelH either
upstream or downstream of green fluorescent protein (GFP) and
localized this fusion protein to the nucleus in transfected mammalian cells, whereas mutations in the RKRK motif resulted in the
cytosolic protein. Interestingly, the full-length SelH-GFP fusion
protein localized specifically to nucleoli, whereas the N-terminal
sequence of SelH fused to GFP had a diffuse nucleoplasm location.
Northern blot analyses revealed low expression levels of SelH
mRNA in various mouse tissues, but it was elevated in the early
stages of embryonic development. In addition, SelH mRNA was
overexpressed in human prostate cancer LNCaP and mouse lung
cancer LCC1 cells. Down-regulation of SelH by RNA interference
made LCC1 cells more sensitive to hydrogen peroxide but not to
other peroxides tested. Overall, these data establish SelH as a novel
nucleolar oxidoreductase and suggest that some functions in this
compartment are regulated by redox and dependent on the trace
element selenium.

Characterization of Novel Mammalian Selenoprotein H

EXPERIMENTAL PROCEDURES
Materials—Chemicals were from Sigma, restriction enzymes
from Amersham Biosciences, DNA purification kits from Qiagen, and mammalian cell culture reagents from Invitrogen.
Primers used in the study are shown in supplemental Table S1.
Multiple Sequence Alignment, Topology Prediction, and
Structural Motif Search for SelH—All detected SelH sequences
were extracted from GenBankTM nonredundant and EST databases and analyzed by BLAST (30) and ClustalW software (31).
Localization of SelH was predicted using PSORT II (32). PSIBLAST/PHI-BLAST (33) searches with the default setting were
carried out to detect conserved protein domains. The HHpred
web-based program (34) was used for fold prediction.
Recombinant Protein Expression in Escherichia coli and Antibody Production—Mouse SelH cDNA clone was purchased
from Research Genetics. The Sec codon was substituted with
that coding for Cys using QuikChange II kit (Stratagene) and
the coding sequence was PCR-amplified and cloned into
pET28a (Novagen). The resulting expression construct was further mutated to obtain CXXS and SXXC variants.
Expression in E. coli BL21 DE3 cells (Novagen) and purification of the recombinant His-tagged protein using TALON resin
(Clontech) was carried out according to the manufacturer’s
protocols. Rabbit polyclonal antibodies against the recombinant protein were produced by Covance.
Activity Assays—Glutathione peroxidase (GPx) activity was
measured by a coupled reaction with glutathione (35) using
hydrogen peroxide or tert-butyl hydroperoxide (t-BOOH) as
substrates and monitoring the decrease in NADPH absorbance at 340 nm according to the manufacturer’s protocol
(BOIXYTECH GPx-340 assay kit, Oxis Research). The
enzyme unit was defined as the amount of protein needed to
catalyze the oxidation of 1 mol NADPH/min. We assayed
both Cys and Ser mutant forms of recombinant SelH and
used mouse liver lysate as control.
Identification of Target Proteins—Targets of SelH were identified by trapping mixed disulfides formed between affinity resAPRIL 20, 2007 • VOLUME 282 • NUMBER 16

ins containing mutant SelH forms and proteins from a nuclear
fraction of LCC1 cells. The affinity resins were prepared by
cross-linking recombinant SelH proteins (CXXS and SXXC
forms) to N-hydroxysuccinimide ester-activated Sepharose
(GE Healthcare) according to the recommendations of the
manufacturer. Nuclear fraction of LCC1 cells was prepared by
differential centrifugation, homogenized in phosphate-buffered saline (PBS) containing protease inhibitors (Roche
Applied Science), and incubated with SelH-immobilized NHSSepharose resins for 1 h at 25 °C. The resins were extensively
washed with PBS to remove nonspecifically bound proteins.
The resins were then resuspended in 50 mM Tris-HCl, pH 8.0,
200 mM NaCl, 10 mM dithiothreitol, and incubated for 30 min at
25 °C. The eluted samples were fractionated by SDS-PAGE, and
proteins were silver-stained. The stained bands were excised
and subjected to liquid chromatography tandem mass spectrometry. Data base searches of the acquired tandem mass
spectra were performed using Mascot (Matrix Science, version
1.9.0, London, UK).
Green Fluorescent Protein (GFP) Fusion Constructs—A set of
chimera proteins included SelH fused C- or N-terminally with
GFP. In brief, we amplified wild-type mouse SelH cDNA (construct number 5), prepared its Sec38Cys mutant, and cloned it
into pEGFPN2 and pEGFP-C3 vectors (Clontech). We also prepared a construct by cloning a sequence coding for a 3-kDa
N-terminal portion of SelH upstream of GFP (construct number 3). A putative nuclear localization signal (NLS) was disrupted by mutating arginines 6 and 8 to serines using the
QuikChange II kit (Stratagene), and for each chimera, the corresponding mutant with disrupted NLS was obtained. Transfection of NIH 3T3 cells was performed using Lipofectamine
(Invitrogen), and the images were captured using an Olympus
FV500 inverted focal microscope at the University of NebraskaLincoln Microscopy Core Facility.
Immunohistochemistry—NIH 3T3 cells were seeded on coverslips and transfected with SelH-GFP fusion constructs. After
24 h, the cells were washed with PBS and fixed by flashing with
ice-cold methanol containing 0.1% Triton X-100 followed by a
5-min treatment with 4% paraformaldehyde. The cells were
then treated with blocking solution (Roche Applied Science)
and incubated with rabbit anti-nucleolin antibodies (Novus
Biologicals) and mouse monoclonal anti-UB2 antibodies (RDI
Research Diagnostics) concurrently followed by washing with
PBS and treatment with donkey anti-mouse Cy5-conjugated
and monkey anti-rabbit Cy3-conjugated antibodies (Jackson
ImmunoResearch Laboratories). The samples were then
washed with PBS and distilled water and mounted with Gel/
Mount (Biomeda). Dilutions of all commercial antibodies were
as suggested by the manufacturers.
Gene Expression Analyses—An in silico expression analysis
was performed using the SAGE Genie web resource (cgap.
nci.nih.gov/SAGE) (36). Pre-made Northern blot membranes
(mouse adult tissue blot and mouse conceptus embryonic tissue
blot) were purchased from Seegene and probed with 0.3-kb
32
P-labeled (Redivue [32P]dCTP, Amersham Biosciences) SelH
cDNA. The probe was generated using the Rediprime II random prime labeling system (Amersham Biosciences) in accordance with the manufacturer’s protocol. To analyze the expresJOURNAL OF BIOLOGICAL CHEMISTRY
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by two other amino acids. This feature is also present in several
other mammalian selenoproteins (i.e. SelW, SelT, SelM, and
SelV), but the physiological roles of these selenoproteins are
also not known. Structures of SelM (23) and its distant homolog
Sep15 (24) have recently been determined (25). Both proteins
possess a thioredoxin-like domain and reside in the endoplasmic reticulum, suggesting that these two proteins are thioldisulfide isomerases with a role in disulfide bond formation.
Among other CXXU-containing selenoproteins, SelW is a
better characterized protein, but its function also has not been
defined (26). It is the smallest mammalian selenoprotein existing in the form of several isoforms that differ by post-translational modifications (27, 28). SelW is expressed in various tissues and is abundant in muscle. Reduced levels of SelW have
been attributed to white muscle disease (29). SelV is a testisspecific distant homolog of SelW having an additional domain
of unknown function (20). Here we used computational, molecular, and cell biology techniques to characterize SelH, which
revealed that this protein is a nucleolar oxidoreductase with an
unusual expression pattern.

Characterization of Novel Mammalian Selenoprotein H
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were washed twice with PBS and incubated in 100 l of serum/
phenol red-free medium containing the indicated (Fig. 6B) concentrations of hydrogen peroxide or 0 –1 mM t-BOOH, cumyl
hydroperoxide or paraquat for 1 h at 37 °C. To examine sensitivity to menadione, we used 0 –30 M treatment with this compound for 6 h. 20 l of CellTiter 96 AQueous One Solution reagent were added to each well and incubated for an additional
4 h. The A490 value was recorded using an ELx808 Ultra microplate reader (Bio-Tek Instruments). Cell viability was calculated as the percentage of untreated controls, and the wells
without cells were used as a blank.
Evolutionary Analysis—Amino acid sequence alignment of
SelH sequences was generated using the PileUP program. The
distances between sequences were calculated from these alignments using the DISTANCE program with the Kimura distance-measuring method, and then the unrooted phylogenetic
tree with unscaled distance branches was generated using the
GrowTree program with the unweighted pair-group method.
All programs were part of the Wisconsin Package, Genetic
Computer Group, Madison, WI (43).

RESULTS AND DISCUSSION
SelH Is a Putative Nuclear Oxidoreductase—Available SelH
sequences were collected and assembled into a multiple sequence
alignment (Fig. 1A). SelH sequences contain a conserved CXXU
motif, which is flanked upstream by a predicted ␤-strand and
downstream by a predicted ␣-helix. This arrangement is highly
similar to thiol/disulfide oxidoreductases of the thioredoxin
fold; however, the latter proteins have a CXXC motif instead of
CXXU (44, 45). The use of advanced BLAST programs (PSIBLAST/PHI-BLAST) (33) with several iterations revealed a distant homology to thioredoxin fold proteins. Indeed, further
analysis with HHPred identified a thioredoxin-like fold in SelH.
Structural alignment places the CXXU motif in SelH in the
same place as the CXXC motif in thioredoxin. These data
suggest that SelH is an oxidoreductase that uses its CXXU
motif as the reversible thiolselenol/selenenylsulfide redox
group.
Sequence analysis also revealed nuclear localization signals
(46) in SelH sequences. Remarkably, SelH proteins have a high
content of basic residues (18.3% in mouse and 22.2% in
zebrafish) due to the high occurrence of arginines and lysines.
By using PSORT II, we found six putative NLSs in the SelH
sequences of chickens (all monopartite), three in zebrafish (all
monopartite), and eight in mice and humans (six monopartite
and two bipartite). Comparison of NLS location and conservations using the multiple sequence alignment showed that only
two NLS were conserved, of which one was in the N-terminal
and one in C-terminal sequences. Within the N-terminal NLS,
the two strictly conserved residues were Arg-6 and Arg-8 (Fig.
1A) (numbering based on the mouse SelH sequence), suggesting that these residues have a critical role in nuclear import as a
part of NLS.
Peroxidase Activity of Recombinant SelH—To further elucidate whether SelH is an oxidoreductase, we performed several
biochemical tests with recombinant mutant forms of the protein in which the Sec residue was substituted with Cys or Ser.
Specifically, these mutants were assayed for thioredoxin, perVOLUME 282 • NUMBER 16 • APRIL 20, 2007
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sion in cell lines, total RNA was isolated using the RNAqueous
kit (Ambion), separated on an agarose gel, transferred onto a
Zeta-Probe blotting membrane (Bio-Rad, protocol from (37)),
and probed as described above.
Western Blot Analyses—Tissues were extracted from euthanized mice, frozen in liquid nitrogen, and stored at ⫺80 °C until
the day of analysis. The tissues were homogenized in PBS containing complete protease inhibitors (Roche Applied Science),
and the lysates were normalized with regard to protein concentration. 10% BisTris NOVEX gels (Invitrogen) were used, and
each well was loaded with 25 g of protein. Following SDSPAGE, the proteins were transferred onto polyvinylidene
difluoride membranes (Invitrogen) and probed with antiSelH antibodies. Secondary horseradish peroxidase-conjugated antibodies were from Amersham Biosciences, and
chemiluminescent peroxidase substrate was from Sigma.
Lysates from various human cancer cell lines (a generous gift
from Dr. Katerina Gurova, Cleveland BioLabs) were examined as described above.
Cell Culture Labeling, Subcellular Fractionation, and Nucleoli Preparation—Experiments involving metabolic labeling of
selenoproteins were carried out by adding 75Se ([75Se]selenious
acid; specific activity 1,000 Ci/mmol, Research Reactor Facility,
University of Missouri, Columbia, MO) to the culture medium
as described previously (38). Separation of cytoplasm and
nuclear fractions was performed as described elsewhere (39). In
brief, following labeling for 48 h, cells were trypsinized, washed
with PBS, homogenized using a tight pestle in 0.25 M sucrose
buffer containing complete protease inhibitor mixture (Roche
Applied Science), and cytosolic and nuclear fractions were separated by differential centrifugation. The resulting cellular fractions were normalized in regard to protein concentration, subjected to SDS-PAGE, and transferred onto polyvinylidene
difluoride membrane, and then 75Se-labeled proteins were visualized with a Storm PhosphorImager system (Amersham Biosciences). Further subfractionation of nuclear compartments to
obtain nucleoli and nucleoplasm fractions was conducted as
described previously (40) with modifications (41).
RNA Interference in LCC1 Cell Line and Oxidative Stress—
To knock down SelH gene expression, five separate 21-nucleotide sequences were selected from SelH cDNA as being unique
using the online service “siDESIGN” of Dharmacon Research,
Inc. These small interfering RNA constructs of pU6-m3 were
prepared as described previously (42). The sequences of all five
SelH small interfering RNA constructs were confirmed. The
five constructs and the pU6-m3 negative control plasmids
were separately transfected into LLC1 cells. After stabilizing
the transfected cells with 0.8 mg/ml hygromycin, SelH mRNA
levels were determined by Northern blot analysis. Based on
mRNA levels, the best small interfering RNA target sequences
of SelH were identified as 5⬘-GAA TTG AAG AAG TAC CTT
TCA-3⬘. These small interfering RNA constructs were used in
subsequent experiments.
Sensitivity of LCC1 cells to oxidative stress was analyzed by
the CellTiter 96 AQueous One Solution cell proliferation assay
(Promega). 5 ⫻ 103 cells were seeded into each well in 96-well
plates and grown overnight in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum. The cells
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doreductase activity of SelH. The
natural oxidoreductase activity of
SelH, however, remains unknown,
and further studies will be needed to
identify specific substrates/targets
of this protein.
Identification of Target Proteins—
The finding that SelH possesses a thioredoxin fold and has a putative
CXXU redox motif suggests analogy
with thioredoxin-like proteins that
form transient disulfides with target
proteins. Mutation of a resolving
Cys in the CXXC motif of thioredoxin often results in stabilization
of such complexes (51–53). We utilized this approach to trap the target
proteins of SelH. Affinity resins
were prepared by linking CXXS and
SXXC forms of recombinant SelH
and incubating with a nuclear fraction prepared from LCC1 cells. A
silver-stained gel showing proteins
eluted from the resins is shown in
supplemental Fig. S1. Proteins
enriched on the SelH resins were
then identified by tandem mass
spectrometry sequencing. Among
those detected in the samples were
FIGURE 1. Redox properties of SelH. A, multiple sequence alignment of SelH sequences. The locations of CXXU several thiol oxidoreductases (e.g.
(which corresponds to the CXXC motif in thioredoxins) and NLS motifs are indicated by boxes, respectively. The peroxiredoxins 1 and 2, thiorepredicted secondary structure is shown above the sequence. B, glutathione peroxidase activity of SelH. The doxin, and glutaredoxin), which is
indicated recombinant forms of SelH (CXXS and CXXC forms) or mouse liver lysate were assayed for GPx activity
as described under “Experimental Procedures.” Reactions were initiated by adding 300 M H2O2 or 233 M consistent with the redox nature of
t-BOOH as the substrate. mU, milliunits.
interactions between SelH and target proteins. Interestingly, most
oxiredoxin, and GPx activities. In the thioredoxin assay, mam- other identified proteins have previously been described as
malian thioredoxin reductase 1 was used as the reductant and nucleolar proteins (e.g. pre-mRNA processing protein 8, puta5,5⬘-dithiobis-(2-nitrobenzoic acid) as the oxidant (47, 48), and tive pre-mRNA splicing factor RNA helicase (DEAH box proa separate assay involved insulin reduction, as in the corre- tein 15), nucleolin, 60 S ribosomal protein L18, ribosomal prosponding assay of thioredoxin function (49). We could detect tein S28). It should be noted that the identified proteins should
no thioredoxin activity of SelH (data not shown). The peroxire- only be viewed as preliminary targets. Further studies will be
doxin activity was examined in an assay of protection of gluta- required to functionally characterize these interactions and
mine synthetase activity (47). SelH also showed no activity in determine their specificity.
Localization of SelH-GFP Fusion Constructs—To test
this assay. Interestingly, SelH had a significant GPx activity (Fig.
1B). This activity was detected only with hydrogen peroxide, whether SelH is a nuclear protein and whether Arg-6 and Arg-8
whereas t-BOOH was not active as a substrate. The Cys mutant are responsible for its location, we prepared and transiently
had four times higher activity than the Ser mutant of SelH. We expressed various SelH-GFP fusion proteins in NIH 3T3 cells
further compared the GPx activity of SelH with that of mam- (Fig. 2A). In these experiments, we used a Sec38Cys mutant
malian GPx1 using mouse liver lysate and quantitative Western form of SelH, which was placed upstream (construct 1) and
blot analysis of GPx1 amounts in the sample (not shown). This downstream (construct 5) of GFP. In addition, we fused a
comparison revealed that the GPx activity of the Cys mutant 3-kDa N-terminal portion of the protein that contains the
was 2,000 – 4,000-fold lower than that of natural mouse liver putative NLS with GFP (construct 3). We also placed a fullGPx1 under the conditions used in the assay. It should be length SelH cDNA sequence including a 3⬘-UTR containing
pointed out that, although SelH had a much lower activity than a SECIS element downstream of GFP as described previously
GPx1, we assayed the Cys form of the natural Sec-containing (20). For each of these four constructs, we developed
SelH. In addition, the peroxidase activity detected was similar mutants in which Arg-6 and Arg-8 were mutated to serines.
to the activities of peroxiredoxins in the reduction of hydroper- Western blot analysis (Fig. 2B) of cells transfected with these
oxides. Thus, these data provided further evidence for the oxi- constructs revealed correspondence of the actual sizes of the
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FIGURE 2. Localization of SelH. A, organization of SelH-GFP fusion constructs utilized in the localization experiments. SelH was fused either upstream or
downstream of GFP, and for each construct, the two conserved arginines in the NLS motif were mutated to serines. In addition, to increase expression levels, Sec was
mutated to Cys in several constructs as shown in the figure. In the constructs expressing a selenoprotein form of SelH, a 3⬘-UTR was included that contained a SECIS
element. B, detection of SelH-GFP fusion proteins by Western blots using anti-SelH antibodies. Migration of expressed proteins corresponded to their predicted
masses and is indicated by arrows on the right. Lanes 1– 8 contain proteins generated from the corresponding constructs shown in A above. C, confocal microscopy of
GFP-SelH fusion protein constructs containing an N-terminal SelH. Three images are shown for each construct. Left panels show green (GFP) fluorescence, middle panels
DAPI staining (nuclear marker), and right panels images obtained by merging the left and middle panels. Numbering from 1 to 4 corresponds to A above. D, Same as in
C, except that SelH was fused downstream of GFP in the SelH-GFP protein. Numbering from 5 to 8 corresponds to A above.
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icant premature termination at
the Sec position. Full-length Seccontaining SelH-GFP fusion proteins were not detectable using
available anti-SelH antibodies.
GFP fluorescence in transfected
cells resulting from SelH-GFP
fusion proteins was determined by
dual wavelength confocal microscopy in parallel with a nuclear
marker (DAPI). We found that,
when NLS was present in proteins,
fluorescence was localized to the
FIGURE 3. SelH is a nucleolar protein. Cells transfected with SelH-GFP (upper panel, construct 1 in Fig. 2) or nuclear fraction (Fig. 2, C and D;
GFP-SelH (lower panel, construct 7) were double-labeled with ␣-U2B antibodies (blue) and ␣-nucleolin antibod- panels 1, 3, 5, and 7), and when the
ies (red). The right image is a merge of the three other images.
arginines were mutated, the fluorescence signal was confined to the
cytosol (Fig. 2, C and D; panels 2, 4, 6, and 8). Thus, SelH is a
nuclear protein possessing a RKRK monopartite NLS, and the
arginines in this motif are essential for nuclear targeting of the
protein.
SelH Is a Nucleolar Protein—As shown in Fig. 2, C and D,
fluorescence inside nuclei that reflected localizations of proteins derived from constructs 1, 3, 5, and 7 was heterogeneous.
In fact, both the SelH-GFP and GFP-SelH forms appeared to be
enriched in nucleoli, whereas when only the NLS-containing
N-terminal peptide was fused to GFP (construct 3), fluorescence was diffused throughout the nuclear compartment.
Interestingly, in the Sec-containing SelH-GFP fusion protein
(construct 7), which migrated as a 310-kDa protein in Western
blot assays (Fig. 2B) (indicating significant premature termination at the UGA codon), the fluorescent signal was not diffused
but still differed from the typical nucleolar staining. We subjected the cells transfected with constructs 1 and 7 to immunohistochemical analysis and used markers for nucleolar and
nucleoplasm staining in parallel. As shown in Fig. 3, upper
panel, the full-length SelH co-localizes with nucleolin, a nucleolar marker, indicating that SelH is indeed a nucleolar protein.
However, the location of the 3-kDa portion of SelH fused to
GFP (construct 7) was surprising, as it appeared to be present in
the nucleoplasm. Taken together, these data indicate that SelH
is a nucleolar protein and that its correct localization required
the full-length folded protein. The nucleolar location of SelH is
also consistent with the abundance of nucleolar proteins that
were enriched on the SelH resins.
The nucleolus has long been known as a dense subnuclear
structure where ribosome biogenesis occurs (for reviews, see
Refs. 54 and 55). Unlike the nucleus and other membrane-restricted organelles, there is no evidence for the occurrence of a
frontier separating the nucleolus from the surrounding nucleFIGURE 4. Expression of SelH during development and in cancer cells. oplasm (56, 57). It is thought that any molecule could migrate in
Northern blot analysis of SelH mRNA expression is shown. Upper panels in A–C and out of the nucleolus and that targeting of particular cellular
show SelH expression and lower panels (controls), expression of 28 and 18 S
ribosomal RNAs. Expression during embryonic development (A), in mouse components to the nucleolus depends on interactions with the
tissues (B), and in the indicated cells (C) is shown.
co-called nucleolar binding blocks (58).
Expression of SelH mRNA—To analyze SelH gene expression,
fusion proteins to the calculated masses, except for the wild- we initially carried out an in silico expression analysis using
type SelH-GFP fusion proteins (constructs 7 and 8 on Fig. 2A mouse and human expression data that is available in the form
and lanes 7 and 8 on Fig. 2B, respectively), because of signif- of supplemental Figs. S2 and S3. Both mouse and human SelH
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mRNA appeared to be moderately expressed in many, if not all,
tissues and organs. However, the majority of expressed
sequence tags were derived from either embryonic or tumor
cells, particularly from carcinomas. Moreover, analysis of
SAGE datasets suggested that expression of human SelH is elevated in some tumors, especially thyroid, lung, stomach, and
liver cancers. In cell lines, SelH appeared high in embryonic
samples, carcinomas, and cell lines derived from bone marrow.
In mouse, it appeared to be elevated in developing brain. Interestingly, we previously found that, during zebrafish development, SelH localized within highly proliferative tissues such as
the brain ventricular zone, part of the retina and tectum at 24
hpf, and later in branchial arches and pectoral fin buds and the
proliferative zone of the retina (59). In addition, zebrafish SelH
was identified as essential for embryonic and early larval development (60).
To directly examine SelH mRNA expression, we carried out
Northern blot analyses using mouse embryonic and adult tis-
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sues and a number of available cell lines (Fig. 4). As expected, we
detected SelH mRNA in various tissues. The signal was particularly strong in samples from early stages of embryogenesis and
in the adult tissues of thymus, brain, testis, and uterus (Fig. 4, A
and B). In cell lines, SelH mRNA expression was elevated in
LCC1 (lung cancer), LNCaP (human prostate carcinoma),
MCS1 (mouse Sertoli cells), and NIH 3T3 (mouse fibroblasts)
cell lines.
Expression of SelH in Mouse Tissues and Human Cancer Cell
Lines—To further elucidate the expression of SelH, we carried
out Western blot analysis (Fig. 5). SelH was abundant in mouse
spleen but was expressed in lower levels in the brain and was
not detected in the other organs examined (Fig. 5A). In addition, we analyzed cancer cell lines and found that SelH expression was dissimilar in various cells, but as expected, it was high
in LNCaP, LCC1, and several other cell lines (Fig. 5B).
We metabolically labeled LNCaP cells with 75Se and then
prepared nuclear and cytoplasmic fractions (Fig. 5C). A 14-kDa
band corresponding in size to SelH was enriched in the nuclear
fraction. The nuclear fraction was further fractionated into
VOLUME 282 • NUMBER 16 • APRIL 20, 2007
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FIGURE 5. Expression of SelH in mouse tissues. Western blot analysis of SelH
expression in mouse tissues (A) and indicated cell lines (B) is shown. C, subcellular fractionation of 75Se-labeled LCC1 cells. Note enrichment of thioredoxin reductase 1 and GPx1 in the cytosolic fraction, whereas the nuclear
fraction had 14- and 25-kDa selenoproteins. D, SelH localizes specifically to
the nucleolar compartment. Western blot analysis using SelH (upper panel)
and nucleolin (lower panel (control)) is shown. E, direct immunohistochemistry of SelH in LCC1 cells.

FIGURE 6. SelH-deficient cells are sensitive to hydrogen peroxide treatment.
A, verification of knockdown cells. The upper panel shows Northern blot analysis
using the SelH probe, middle panel (control) shows Northern blot analysis using
the GAPDH probe, and the lower panel shows Western blot analysis using antiSelH antibodies. The left lane shows cells transfected with a control vector and
the right lane, SelH knockdown cells. B, viability of control and SelH knockdown cells treated with the indicated concentrations of hydrogen peroxide is
shown.
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protein in redox reactions and
observed specificity of SelH for
hydrogen peroxide compared with
t-BOOH.
Nucleoli have been shown to be
involved in oxygen-dependent regulatory mechanisms via the hypoxia-inducible factor (HIF-1). This
protein is degraded under conditions of normal oxygen tension but
is stabilized in hypoxia by VHL (von
Hippel-Lindau, a tumor suppressor
protein) activating a set of genes
implicated in oxygen homeostasis,
tumor vascularization, and ischemic preconditioning (65, 66). It has
been shown that hypoxia can neutralize the function of VHL by triggering its nucleoli sequestration
FIGURE 7. Phylogenetic analysis of SelH sequences. Animal SelH sequences are split into three branches, the (67– 69). This mechanism undermajor of which is the SelH branch, and the two other groups include fruit fly sequences representing non- lines the importance of redox status
selenoprotein SelH homologs. More distantly related plant sequences have a CXXC motif. The accession num- in nucleoli, and we speculate that
bers (GenBankTM) are as follows: Gallus gallus SelH (46017578), Danio rerio SelH (31342376), Tetradon SelH
(56305185), Anopheles gambiae SelH (27645579), Drosophila melanogaster BthD (14718671), Arabidopsis thali- SelH, being a nucleolar oxidoreducana SelH1 (30689011), Arabidopsis thaliana SelH2 (50058858), Drosophila melanogaster SelH3 (24584864), Dro- tase, may play a related role. Moresophila melanogaster SelH2 (113194556), Mouse SelH (82546880), Rat SelH (109470184), Pig SelH (87230686),
over, being a selenoprotein, SelH
Human SelH (3516960), Ciona savignyi SelH (51695500), Ciona intestinalis SelH (56083593), Drosophila yakuba
SelH3 (84681766), Drosophila simulans SelH3 (61736437), Drosophila yakuba SelH2 (84681627), Drosophila may mediate certain effects of diesimulans SelH2 (111276688), Drosophila yakuba BthD (84679567), and Drosophila simulans BthD (61714200).
tary selenium on nucleolar function.
Evolutionary Analyses—A SelH
phylogenetic tree was constructed
nucleolar and nucleoplasm fractions. By Western blot analysis, based on the available SelH sequences. As shown in Fig. 7, varSelH was detected in the nucleolar fraction, in similar manner ious Drosophila species have evolved two additional homologs
as the control protein nucleolin (Fig. 5D). Subsequent immu- of the protein, which form separate branches from the selenonohistochemistry analysis further verified the presence of SelH protein forms of the protein. Interestingly, additional fruit fly
in nucleoli (Fig. 5E).
homologs have neither CXXC nor CXXU motifs. Instead, SelH3
Nucleoli are best known as a site for rRNA biosynthesis and possesses a CXXR and SelH2 a CXXT motif, the latter more
modification. However, nucleoli have additional functions, typical of peroxiredoxins and glutathione peroxidases, which
such as virus infection control, maturation of non-nucleolar are large families of thiol peroxidases involved in various bioRNAs and RNPs, regulation of telomerase function and cell logical processes (50, 70). These data suggest functional differcycle, tumor suppressor and oncogene activities, and cell stress ences between SelH and the two Drosophila homologs. It is also
sensing and signaling (61– 63). Moreover, by proteomic possible that various functions of mammalian SelH are carried
approaches, many uncharacterized proteins have been identi- out by separate proteins in fruit flies.
fied in nucleoli, suggesting additional unknown functions for
this compartment (41, 64).
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activity, this protein was further examined for antioxidant
functions. We employed RNAi to suppress SelH expression and
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Supplementary data
Table S1. Primers used in the study.
1. Primers used for mutating CxxU motif
Forward_CxxC -5’-GCATTGTACGAGCTGTCGCGTGTACGGCCGCCATGC-3’
Reverse_CxxC -5’-GCATGGCGGCCGTACACGCGACAGCTCGTACAATGC-3’
Forward_CxxS -5’-GCATTGTACGAGCTCACGCGTGTACGGCCGCCATGC-3’
Reverse_CxxS -5’-GCATGGCGGCCGTTGACGCGACAGCTCGTACAATGC-3’
Forward_SxxC -5’-CCGTGGTCATTGAGCATAGTACGAGCTGTCGCGTGTAC3’
Reverse_SxxC -5’-CCGTACACGCGACAGCTCGTACTATGCTCAATGACCAC3’
2. Primers used to mutate arginines 6 and 8 to serines:
ATGGCCCCCCACGGAAGTAAGAGTAAGGCGGGGGCCGCG
CGCGGCCCCCGCCTTACTCTTACTTCCGTGGGGGGCCAT
3. Primers used for cloning into pET:
Forward -5’-TAAACGA CATATGGCCCCCCACGGAAG AAAG-3’
Reverse -5’-CTACC'TCGAGTTATGAAAGGTACTTCTTCAATTC-3’
4. Primers used for cloning into pEGFP-N2:
Forward -5’-CTAAGAATTC ATGGCCCCCCACGGAAGAAAG-3’
Reverse 1 -5’-CGTAGGATCCATGAAAGGTACTTCTTCAATTCTTCAACC-3’
Reverse 2 -5’-CGTAGGATCCTCGCGCCCTCCGCCAGTTTCTC-3’
5. Primers used for cloning into pEGFP-C3:
Forward -5’-CTACCTCGAGTTATGAAAGGTACTTCTTCAATTC-3’
Reverse 1 -5’-GCAAGGATCCGAAACACTTTTACAATGTCTTGC-3’
Reverse 2 -5’-CTACC'TCGAGTTATGAAAGGTACTTCTTCAATTC-3’
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Fig. S1

Fig. S1. Identification of SelH target proteins in LCC1 cells. This silver stained SDS PAGE
gel shows nuclear proteins from LCC1 cells enriched on SxxC-SelH and SxxC-SelH resins. Due
to close similarity of targets identified in each of the variants, the targets are labeled only for one
mutant. Migration of molecular weight standards is shown on the right. The following proteins
were identified by MS/MS sequencing of protein bands extracted from the gel: 1 - pre-mRNA
processing protein 8, 2 - putative pre-mRNA splicing factor RNA helicase (DEAH box protein
15), 3 - nucleolin, 4 - nuclear cap binding protein subunit 1, 5 - PTB-associated splicing factor, 6
- heterogeneous nuclear ribonucleoprotein R, 7 - IGF-II mRNA-binding protein 2, 8 - nucleolar
protein, 9 - glyoxylate reductase/hydroxypyruvate reductase, 10 - poly(rC) binding protein 1 and
heterogeneous nuclear ribonucleoprotein X, 11 - Rbbp5 protein, 12 - spliceosome-associated
protein SAP 62, 13 - nucleophosmin 1 and nucleolar protein NO38, 14 - heterogeneous nuclear
ribonucleoprotein A1 (helix-destabilizing protein), 15 - peroxiredoxin 1, natural killer-enhancing
factor A and proliferation-associated gene, 16 - peroxiredoxin 2, 17 -60S ribosomal protein L18,
18 - glutaredoxin, 19 - thioredoxin 1, and 20 - ribosomal protein S28.
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Fig. S2
A

B

Fig. S2. Computational analysis of SelH mRNA expression profiles using publicly available
expression data. A. GeneNote database contains data on whole genome mRNA expression
profiles in normal human tissues. Two organs that showed the highest SelH mRNA levels in
humans are thymus and spleen. B. Gene Atlas database contains data on whole genome mRNA
expression profiles in normal human and mouse tissues. Similar to human, two organs with the
highest SelH mRNA levels in mouse are thymus and spleen.
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Fig. S3

Library

Total Tags in
Library

Embryonic stem cell HES3 normal p16 CL SHE10

SelH Tags per
200,000

205353

105

86391

90

Embryonic stem cell H9 normal p38 CL SHES1

151735

90

Embryonic stem cell H1 normal p54 CL SHE16

218214

82

Liver cholangiocarcinoma B K2D

46853

76

Breast carcinoma CL ZR75 1 untreated

32303

74

Bone marrow normal AP CD34+/CD38+/lin+

81595

73

Breast carcinoma CL MCF7 control 0h

59877

73

212170

73

Lung adenocarcinoma B 1

36256

71

Colon carcinoma CL Hct116 wildtype p53 Normal
Oxygen

80398

69

Prostate carcinoma CL LNCaP-T

43542

68

Colon carcinoma CL Hct116 p53 knockout Anoxia

79053

65

Pancreas carcinoma CL ASPC

31224

64

Bone marrow normal AP CD34+/CD38-/lin-

Emryonic stem cell H14 normal p22 CL SHE14

Fig. S3. SAGE Genie in silico expression analysis of SelH expression.
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